CorMedix Inc. — Director's Dealing 2014

Jul 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2014-07-21

Reporting Person: O'Grady Harry (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-21	Stock Option (Right to Buy Common Stock)	$1.8	A	100000	Acquired	2024-07-21	Common Stock (100000)	Direct

Footnotes

F1: These options were granted on July 21, 2014, and vest over a three-year period with one-fourth (1/4) of the options granted vesting on the grant date and each of the first, second and third anniversaries of the grant date.